Get started
Author

Jodie Anne Schildkraut

Observed names: J. A. Schildkraut, J.A. Schildkraut, Jodie A Schildkraut, Jodie A. Schildkraut, Jodie Schildkraut, Schildkraut, J.A., Schildkraut, Jodie, Schildkraut, Jodie A.
ORCID: 0000-0002-7236-8934
Observed ORCID: 0000-0002-7236-8934
OpenAlex ID: A5085258368
The shape of the iceberg: quantification of submicroscopic Plasmodium falciparum and Plasmodium vivax parasitaemia and gametocytaemia in five low endemic settings in Ethiopia
2017 · Fitsum G. Tadesse, Lotus van den Hoogen, et al. · Malaria Journal · 79
PDF
Molecular Markers for Sensitive Detection of Plasmodium falciparum Asexual Stage Parasites and their Application in a Malaria Clinical Trial
2017 · Fitsum G. Tadesse, Kjerstin Lanke, et al. · American Journal of Tropical Medicine and Hygiene · 48
PDF
Epidemiology of nontuberculous mycobacterial pulmonary disease in Europe and Japan by Delphi estimation
2020 · Jodie A. Schildkraut, Jack Gallagher, et al. · Respiratory Medicine · 46
PDF
The role of amikacin in the treatment of nontuberculous mycobacterial disease
2021 · Jelmer Raaijmakers, Jodie Anne Schildkraut, et al. · Expert Opinion on Pharmacotherapy · 40
PDF
Unraveling antibiotic resistance mechanisms in Mycobacterium abscessus: the potential role of efflux pumps
2022 · Saskia E. Mudde, Jodie A. Schildkraut, et al. · Journal of Global Antimicrobial Resistance · 34
PDF
The role of rifampicin within the treatment of Mycobacterium avium pulmonary disease
2023 · Jodie A. Schildkraut, Jelmer Raaijmakers, et al. · Antimicrobial Agents and Chemotherapy · 29
Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease
2022 · Sanne Maria Henriette Zweijpfenning, Raphael Chiron, et al. · CHEST Journal · 25
PDF
The epidemiology of nontuberculous mycobacterial pulmonary disease in the Netherlands
2021 · Jodie Anne Schildkraut, Sanne Maria Henriëtte Zweijpfenning, et al. · ERJ Open Research · 22
PDF
Sutezolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-SUDOCU-01): a prospective, open-label, randomised, phase 2b dose-finding trial
2025 · Norbert Heinrich, Norbert Heinrich, et al. · The Lancet Infectious Diseases · 20
PDF
Minocycline Has No Clear Role in the Treatment of Mycobacterium abscessus Disease
2018 · Mike M. Ruth, Jasper J. N. Sangen, et al. · Antimicrobial Agents and Chemotherapy · 19
Delpazolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-DECODE-01): a prospective, randomised, open-label, phase 2b, dose-finding trial
2025 · Lilian Tina Minja, Isabella van der Feltz, et al. · The Lancet Infectious Diseases · 18
PDF
Failure with acquired resistance of an optimised bedaquiline-based treatment regimen for pulmonary Mycobacterium avium complex disease
2019 · Sanne M.H. Zweijpfenning, Jodie A. Schildkraut, et al. · European Respiratory Journal · 18
PDF
Nontuberculous mycobacterial pulmonary disease andAspergillusco-infection: Bonnie and Clyde?
2019 · Kim Geurts, Sanne M.H. Zweijpfenning, et al. · European Respiratory Journal · 17
PDF
Mycobacterium Growth Indicator Tube Time-To-Positivity Can Serve As an Early Biomarker of Treatment Response in Mycobacterium avium Complex Pulmonary Disease
2021 · Rabi Danho, Jodie A. Schildkraut, et al. · CHEST Journal · 14
PDF
Thioridazine Is an Efflux Pump Inhibitor in Mycobacterium avium Complex but of Limited Clinical Relevance
2020 · Mike Marvin Ruth, Lian J. Pennings, et al. · Antimicrobial Agents and Chemotherapy · 14
The potential role of drug transporters and amikacin modifying enzymes in M. avium
2023 · Jodie A. Schildkraut, Jordy P.M. Coolen, et al. · Journal of Global Antimicrobial Resistance · 9
The Differential Effect of Clarithromycin and Azithromycin on Induction of Macrolide Resistance in Mycobacterium Abscessus
2019 · Jodie A Schildkraut, Lian J Pennings, et al. · Future Microbiology · 9
MGIT Enriched Shotgun Metagenomics for Routine Identification of Nontuberculous Mycobacteria: a Route to Personalized Health Care
2023 · Jodie A. Schildkraut, Jordy P. M. Coolen, et al. · Journal of Clinical Microbiology · 8
Genome-wide analysis in Escherichia coli unravels a high level of genetic homoplasy associated with cefotaxime resistance
2021 · Jordy P. M. Coolen, Evert P. M. den Drijver, et al. · Microbial Genomics · 8
Advances in tuberculosis biomarkers: unravelling risk factors, active disease and treatment success
2024 · Jodie A. Schildkraut, Niklas Köhler, et al. · Breathe · 6
Cardiac safety of bedaquiline, delamanid and moxifloxacin co-administered with or without varying doses of sutezolid or delpazolid for the treatment of drug-susceptible TB
2025 · Simon E Koele, Krista Stoycheva, et al. · Journal of Antimicrobial Chemotherapy · 5
PDF
Replacing rifampicin with minocycline increases the activity of the treatment regimen for Mycobacterium avium complex pulmonary disease in a dynamic hollow-fibre system
2024 · Jelmer Raaijmakers, Mike M. Ruth, et al. · International Journal of Antimicrobial Agents · 5
A viable but nonculturable state of Mycobacterium avium in response to macrolide antibiotics: a recipe for relapses?
2025 · Iris Schuiermanni, Eva Terschlüsen, et al. · Journal of Medical Microbiology · 2
If you want to go far, go together: standardisation and data sharing in TB drug development
2024 · J. A. Schildkraut, D. Sloan, et al. · The International Journal of Tuberculosis and Lung Disease · 2
PDF
An optimized protocol for dual RNA-Seq of human macrophages infected with Mycobacterium avium
2021 · Jodie A Schildkraut, Valerie ACM Koeken, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2
PDF
Works count: 39
Citation count: 508
H-index: 14
I10-index: 15
Year
Topic
Type